display
Paris (AP) - The French pharmaceutical company Sanofi plans to deliver more than 125 million doses of the Pfizer Biontech vaccine for the European Union from the summer.
Sanofi wanted to give Mainz-based company Biontech access to its production infrastructure, it said in a statement on Wednesday.
The aim is to take over “late-stage manufacturing steps” to support the delivery of the Covid-19 vaccine.
The first deliveries are to be made from the Sanofi production facilities in Frankfurt in summer 2021.
Sanofi General Director Paul Hudson had already commented on Tuesday.
In an interview with the French newspaper “Le Figaro” he spoke specifically about wanting to help with filling the vaccine.
This needs to be done in a sterile environment and at a very low temperature, he said.
Since the Sanofi production facility in Frankfurt is close to the Biontech headquarters in Mainz, that will make things easier.
"We should be able to deliver more than 100 million cans by the end of the year, which are destined for the European Union and thus partly for France," he said in the conversation.
At the same time, the company wants to continue working on its two Covid-19 vaccines.
The corona vaccine development by Sanofi and the British pharmaceutical company GSK (GlaxoSmithKline) had recently been delayed.
If further studies are successful, Sanofi expects approval of the recombinant protein-based vaccine around the end of 2021. At the same time, Sanofi is developing an mRNA vaccine in partnership with the US company Translate Bio.
“There is no question of giving up,” said Hudson “Le Figaro”.
display
© dpa-infocom, dpa: 210127-99-187457 / 2
Interview (French)